511 related articles for article (PubMed ID: 9893931)
1. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
[TBL] [Abstract][Full Text] [Related]
2. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
[TBL] [Abstract][Full Text] [Related]
3. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological studies of BX661A. 5-[4-(2-carboxyethylcarbamoyl)-phenylazo]-salicylic acid disodium salt dihydrate (1). Therapeutic effects on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) model in rats].
Kimura I; Nagahama S; Kawasaki M; Kataoka M; Sato M
Nihon Yakurigaku Zasshi; 1997 Feb; 109(2):85-94. PubMed ID: 9173000
[TBL] [Abstract][Full Text] [Related]
5. Influences of aflatoxin B1 on reactive oxygen species generation and chemotaxis of human polymorphonuclear leukocytes.
Ubagai T; Tansho S; Ito T; Ono Y
Toxicol In Vitro; 2008 Jun; 22(4):1115-20. PubMed ID: 18316174
[TBL] [Abstract][Full Text] [Related]
6. [Effect of salazosulfapyridine and its metabolites on immunocompetent cells].
Ishibashi T; Hara A; Tsuboi I; Muraoka T; Shibata H; Tsunosue R; Shichijo S; Yokoyama M
Ryumachi; 1989 Jun; 29(3):178-84. PubMed ID: 2573159
[TBL] [Abstract][Full Text] [Related]
7. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
[TBL] [Abstract][Full Text] [Related]
8. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Zinkl JG; Brown PD
Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
[TBL] [Abstract][Full Text] [Related]
9. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
Miyachi Y; Yoshioka A; Imamura S; Niwa Y
Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
[TBL] [Abstract][Full Text] [Related]
10. Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase.
Koshio O; Ono Y
Chemotherapy; 2009; 55(5):363-71. PubMed ID: 19657190
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
13. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of local anesthetics on migration, extracellular release of lysosomal enzyme, and superoxide anion production in human polymorphonuclear leukocytes.
Sasagawa S
Immunopharmacol Immunotoxicol; 1991; 13(4):607-22. PubMed ID: 1663527
[TBL] [Abstract][Full Text] [Related]
15. Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes.
Maio RC; Cosentino M; Rossetti C; Molteni M; Lecchini S; Marino F
Int Immunopharmacol; 2011 Feb; 11(2):194-8. PubMed ID: 21115122
[TBL] [Abstract][Full Text] [Related]
16. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
Molin L; Stendahl O
Acta Med Scand; 1979; 206(6):451-7. PubMed ID: 43662
[TBL] [Abstract][Full Text] [Related]
17. Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.
Nielsen OH; Bouchelouche PN; Berild D; Ahnfelt-Rønne I
Scand J Gastroenterol; 1993 Jun; 28(6):527-32. PubMed ID: 8100641
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
Suematsu M; Suzuki M; Miura S; Nagata H; Oshio C; Asakura H; Watanabe M; Tsuchiya M
J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
[TBL] [Abstract][Full Text] [Related]
19. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids.
Fukushima K; Ando M; Ito K; Suga M; Araki S
J Clin Lab Immunol; 1990 Nov; 33(3):117-23. PubMed ID: 1967000
[TBL] [Abstract][Full Text] [Related]
20. Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma.
Miyatake H; Suzuki K; Taki F; Takagi K; Satake T
Arzneimittelforschung; 1991 May; 41(5):552-6. PubMed ID: 1654910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]